Chris Sander,David Wang,Andrea Califano,Arthur Holden,Rebecca Hyman | GenomeWeb

Chris Sander, formerly head of the scientific informatics division at Millennium Pharmaceuticals, has left the company.A source close to the company said that Sander left the company back in July due to “differences of opinion.”Sander, who is also a visiting scientist at the Whitehead Institute for Biomedical Research, did not return a call seeking comment.Millennium has not decided whether it would find a replacement for Sander.In the meantime, all of the scientific informatics directors who previously reported to Sander are now reporting to Michael Pa

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.